Tuesday, November 5, 2024
HomeTagsDKN-01 Plus

DKN-01 Plus

Leap Therapeutics to Present Positive New Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab

Leap Therapeutics, Inc., a biotechnology company focused on developing targeted and immuno-oncology therapeutics, announced the Company will be presenting updated data from the DisTinGuish...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics